Category:Smita GUNNOO: Difference between revisions
Updating Category:Smita_GUNNOO |
Updating Category:Smita_GUNNOO |
||
| Line 2: | Line 2: | ||
=== Executive Summary === | === Executive Summary === | ||
Smita GUNNOO is an inventor who has filed 2 patents. Their primary areas of innovation include | Smita GUNNOO is an inventor who has filed 2 patents. Their primary areas of innovation include Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (2 patents), Drugs for disorders of the muscular or neuromuscular system (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), and they have worked with companies such as PepGen Inc. (2 patents). Their most frequent collaborators include [[Category:Caroline GODFREY|Caroline GODFREY]] (2 collaborations), [[Category:Sonia BRACEGIRDLE|Sonia BRACEGIRDLE]] (2 collaborations), [[Category:Ashling HOLLAND|Ashling HOLLAND]] (1 collaborations). | ||
=== Patent Filing Activity === | === Patent Filing Activity === | ||
| Line 11: | Line 11: | ||
==== List of Technology Areas ==== | ==== List of Technology Areas ==== | ||
* [[:Category:CPC_A61K47/64|A61K47/64]] ( | * [[:Category:CPC_A61K47/64|A61K47/64]] (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 2 patents | ||
* [[:Category:CPC_A61P21/00|A61P21/00]] ( | * [[:Category:CPC_A61P21/00|A61P21/00]] (Drugs for disorders of the muscular or neuromuscular system): 2 patents | ||
* [[:Category:CPC_C12N2310/11|C12N2310/11]] ( | * [[:Category:CPC_C12N2310/11|C12N2310/11]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents | ||
* [[:Category:CPC_C12N2310/3233|C12N2310/3233]] ( | * [[:Category:CPC_C12N2310/3233|C12N2310/3233]] (modified ring structure): 2 patents | ||
* [[:Category:CPC_C12N15/113|C12N15/113]] ( | * [[:Category:CPC_C12N15/113|C12N15/113]] (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents | ||
* [[:Category:CPC_A61K9/0019|A61K9/0019]] ( | * [[:Category:CPC_A61K9/0019|A61K9/0019]] (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents | ||
* [[:Category:CPC_C07K7/08|C07K7/08]] ( | * [[:Category:CPC_C07K7/08|C07K7/08]] (PEPTIDES (peptides in foodstuffs): 1 patents | ||
* [[:Category:CPC_A61K47/54|A61K47/54]] ( | * [[:Category:CPC_A61K47/54|A61K47/54]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents | ||
* [[:Category:CPC_C12N15/1137|C12N15/1137]] ( | * [[:Category:CPC_C12N15/1137|C12N15/1137]] ({against enzymes (viral enzymes): 1 patents | ||
* [[:Category:CPC_C12N2310/3513|C12N2310/3513]] ( | * [[:Category:CPC_C12N2310/3513|C12N2310/3513]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents | ||
* [[:Category:CPC_C12N2320/35|C12N2320/35]] ( | * [[:Category:CPC_C12N2320/35|C12N2320/35]] (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents | ||
=== Companies === | === Companies === | ||
Latest revision as of 06:39, 18 July 2024
Smita GUNNOO
Executive Summary
Smita GUNNOO is an inventor who has filed 2 patents. Their primary areas of innovation include Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers (2 patents), Drugs for disorders of the muscular or neuromuscular system (2 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (2 patents), and they have worked with companies such as PepGen Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (1 collaborations).
Patent Filing Activity
File:Smita GUNNOO Monthly Patent Applications.png
Technology Areas
File:Smita GUNNOO Top Technology Areas.png
List of Technology Areas
- A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers): 2 patents
- A61P21/00 (Drugs for disorders of the muscular or neuromuscular system): 2 patents
- C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N2310/3233 (modified ring structure): 2 patents
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
- A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
- C07K7/08 (PEPTIDES (peptides in foodstuffs): 1 patents
- A61K47/54 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
- C12N15/1137 ({against enzymes (viral enzymes): 1 patents
- C12N2310/3513 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
- C12N2320/35 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
Companies
File:Smita GUNNOO Top Companies.png
List of Companies
- PepGen Inc.: 2 patents
Collaborators
- Caroline GODFREY (2 collaborations)
- Sonia BRACEGIRDLE (2 collaborations)
- Ashling HOLLAND (1 collaborations)
- Ashling HOLLAND of Boston MA (US) (1 collaborations)
Subcategories
This category has the following 5 subcategories, out of 5 total.